Skip to main content
Clinical Trials/EUCTR2017-003278-15-BE
EUCTR2017-003278-15-BE
Active, not recruiting
Phase 1

Hyperalgesia, Persistent Pain, and Fentanyl Dosing in On-Pump Coronary Artery Bypass Grafting

Ghent University Hospital0 sites69 target enrollmentOctober 30, 2017

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Ghent University Hospital
Enrollment
69
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 30, 2017
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Consenting patients aged \=18 years
  • Undergoing first\-time, elective, on\-pump CABG surgery with median sternotomy and central cannulation.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 46
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 23

Exclusion Criteria

  • Documentation of preexisting chronic pain as per electronic record
  • Use of opioids in the last 30 days or history/documentation of opioid abuse as per electronic record
  • BMI \> 35kg/m2 or history of obstructive sleep apnea syndrome
  • Patients with renal failure (clearance \< 30 ml/min)
  • Neuraxial anesthesia
  • Planned wound infiltration with local anesthetics
  • Known drug allergies or intolerance to fentanyl or other opioids
  • Expected to be unable to understand pinprick/allodynia testing / follow\-up questions

Outcomes

Primary Outcomes

Not specified

Similar Trials